Ibrahim E. Helal

Dr. Ibrahim E. Helal

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2006 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
KMK. Misumi
K. Misumi
MTM. Tagami
M. Tagami
TKT. Kamimura
T. Kamimura
DMD. Miyakoshi
D. Miyakoshi
IHIbrahim E. Helal
Ibrahim E. Helal
MFM. Fujiki
M. Fujiki

1 February 2007 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
IHIbrahim E. Helal
Ibrahim E. Helal
KMKazuhiro Misumi
Kazuhiro Misumi
OTOki Tateno
Oki Tateno
TKTakeshi Kodama
Takeshi Kodama
MIMutsuki Ishimaru
Mutsuki Ishimaru
MFMakoto Fujiki
Makoto Fujiki
Objective—To evaluate changes in serum cartilage oligomeric matrix protein (COMP) concentrations in response to exercise in horses. Animals—15 horses in experiment 1 and 27 horses in experiment 2. Procedures—In experiment 1, 15 Thoroughbreds free of orthopedic disease underwent a standardized exercise protocol. Running velocity and heart rate (HR) were recorded, and blood samples were collected immediately before (baseline) and 1, 5, and 24 hours after a single episode of exercise. In experiment 2, 27 horses underwent 9 stages of a training program in which each stage consisted of 4 to 8 consecutive daily workouts followed by a rest day. Blood samples were collected immediately before the first and final daily workouts in each stage. Serum COMP concentrations were measured via inhibition ELISA with a monoclonal antibody (14G4) against equine COMP. Results—In experiment 1, mean serum COMP concentration was significantly higher than baseline 1 and 5 hours after exercise and returned to baseline concentrations 24 hours after exercise. Mean serum baseline COMP concentration increased as the velocity of running at maximum HR and at an HR of 200 beats/min increased, being significantly higher during the third and fourth exercise tests than during the first. In experiment 2, mean baseline COMP concentration at the final workout of each stage was significantly higher than that at the first workout, beginning with stage 3. Conclusions and Clinical Relevance—Serum COMP concentrations changed significantly in response to exercise. Exercise may enhance movement of COMP into the circulation as well as change the basal turnover rate of COMP.

30 September 2022 in Journal of Animal Science and Technology
Verified
Journal Article
Open access
PDF file
IHIbrahim E. Helal
Ibrahim E. Helal
HAHatim A. Al-Abbadi
Hatim A. Al-Abbadi
MEMohamed H. El-Daharawy
Mohamed H. El-Daharawy
Mahmoud F. AhmedMahmoud F. Ahmed
Mahmoud F. Ahmed
Delayed healing associated with distal limb wounds is highly challenging in equine clinical practice. This study aimed to evaluate healing rates between chronic non-granulating wounds of horse distal limbs that were treated with maltodextrin/ascorbic acid gel alone or in combination with povidone-iodine 1% solution and those treated with povidone-iodine 1% only throughout the study period (35 days) in clinical settings. The study was conducted on 18 adult horses (3–15 years old). Based on the treatment regimen utilized, the horses were divided into three groups (n = 6), with each group having a similar mean wound area. The percentages of wound contraction, epithelialization, and overall wound healing were determined weekly for each wound. By the end of the study, the total wound healing percentage was significantly increased between the study groups (p < 0.05). The use of maltodextrin/ascorbic acid gel resulted in considerable wound contraction, rapid epithelialization, and complication-free wound healing. Based on the findings of this study, maltodextrin/ascorbic acid gel, independently or in combination with a 1% povidone-iodine solution, might be applied as a safe and effective wound healing promoting agent in horses with chronic non-granulating wounds.

Verified
Journal Article
Open access
PDF file
EMElsayed Metwally
Elsayed Metwally
HAHatim Ali Al-Abbadi
Hatim Ali Al-Abbadi
MHMohamed A. Hashem
Mohamed A. Hashem
DADr. Yasmina Kamal Mahmoud Abd-ElAziz
Dr. Yasmina Kamal Mahmoud Abd-ElAziz
EAEman Ali Abdelnaby Ahmed
Eman Ali Abdelnaby Ahmed
Mahmoud F. AhmedMahmoud F. Ahmed
Mahmoud F. Ahmed
Calpain activation has been implicated in various pathologies, including neurodegeneration. Thus, calpain inhibition could effectively prevent spinal cord injury (SCI) associated with neurodegeneration. In the current study, a dog SCI model was used to evaluate the therapeutic potential of a selective calpain inhibitor (PD150606) in combination with methylprednisolone sodium succinate (MPSS) as an anti-inflammatory drug. SCI was experimentally induced in sixteen mongrel dogs through an epidural balloon compression technique. The dogs were allocated randomly into four groups: control, MPSS, PD150606, and MPSS+PD150606. Clinical evaluation, serum biochemical, somatosensory evoked potentials, histopathological, and immunoblotting analyses were performed to assess treated dogs during the study. The current findings revealed that the combined administration of MPSS+PD150606 demonstrated considerably lower neuronal loss and microglial cell infiltration than the other groups, with a significant improvement in the locomotor score. The increased levels of inflammatory markers (GFAP and CD11) and calcium-binding proteins (Iba1 and S100) were significantly reduced in the combination group and to a lesser extent in MPSS or PD150606 treatment alone. Interestingly, the combined treatment effectively inhibited the calpain-induced cleavage of p35, limited cdk5 activation, and inhibited tau phosphorylation. These results suggest that early MPSS+PD150606 therapy after acute SCI may prevent subsequent neurodegeneration via calpain inhibition.

14 September 2024 in International Journal of Pharmaceutics: X
Verified
Journal Article
Open access
PHPierre A. Hanna
Pierre A. Hanna
HAHatim A. Al-Abbadi
Hatim A. Al-Abbadi
MHMohamed A. Hashem
Mohamed A. Hashem
AMAziza E. Mostafa
Aziza E. Mostafa
YMYasmina K. Mahmoud
Yasmina K. Mahmoud
Mahmoud F. AhmedMahmoud F. Ahmed
Mahmoud F. Ahmed
Pain produces several physiological, and degenerative complications. This study aimed to formulate meloxicam (MLX) in liposomes to increase solubility and deliver MLX in a controlled manner to overcome its poor aqueous solubility and relatively short t1/2 problems. Liposomes were prepared by thin film hydration followed by ultrasonication. Tests for characterizing formulations included particle size, span, entrapment efficiency, drug loading, stability, differential scanning calorimetry (DSC), Fourier transformation infrared (FT-IR) spectroscopy, morphology, in vitro release, release kinetics mathematical modeling, and an in vivo pain model in dogs undergoing orthopedic surgeries, followed by in vivo pharmacokinetics, pharmacodynamics, and pain assessment studies in comparison to the reference standard, Mobitil (R). Liposomal MLX had a particle size of around 100 nm, 82 % entrapment efficiency, and 4.62 % drug loading. Stability studies, DSC, and FT-IR spectroscopy indicated that liposomes were highly stable. The formulation showed an improved in vitro controlled release pattern and an enhanced in vivo pharmacokinetic behavior as manifested by higher t1/2 and AUC0-24 and lower Cl/F in comparison to Mobitil (R). The pharmacodynamics study and pain scales demonstrated liposomal MLX managed postoperative pain better than Mobitil (R). In conclusion, the incorporation of MLX in liposomes increased its solubility and stability, as well as its pain management properties.

6 December 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
DEDoaa H. Elsayed
Doaa H. Elsayed
SNSameer A. Nagadi
Sameer A. Nagadi
HAHeba Abdelrazek
Heba Abdelrazek
AEAhmed. S. El‑Hawy
Ahmed. S. El‑Hawy
MEMoharram F. El-Bassiony
Moharram F. El-Bassiony
SHShady T. Hassan
Shady T. Hassan
The study aimed to explore the protective effect of Nannochloropsis oculata (N.oculata) on lead induced reproductive toxicity in rams. Sixteen Barki rams were divided equally in to 4 groups; group A: control, group B: was administered 3 % dietary N. oculate, group C: was gavaged 5 mg/kg/day lead acetate and group D: was supplemented with 3 % dietary N. oculata and gavaged with 5 mg/kg/day lead acetate. The experiment lasted 180 days. Semen and blood samples were obtained. Ejaculates were examined for semen criteria besides, analysis of testosterone. Testicular oxidant/antioxidant markers, cytokines, gene expression of interleukin-6 (IL-6) and nuclear factor Kappa B (NF-κB) were estimated. Alga-treated rams revealed significant upgrades in semen criteria, serum testosterone and reduced glutathione (GSH); meanwhile, downregulation in malondialdehyde (MDA), IL-4, IL-2 as well as gene expressions of IL-6 and NF-κB as compared to other treated groups. However, lead-treated rams showed significant deteriorations in semen criteria and reduced GSH while significant elevations in MDA, IL-4, IL-2 as well as gene expression of IL-6 and NF-κB were noticed than control. Alga supplementation to lead-intoxicated rams significantly upgraded the lead induced alterations that were manifested by improvement in testicular histopathology. In conclusion, the addition of alga mitigated lead induced reproductive toxicity in rams via improving testosterone, oxidant/antioxidant status, semen criteria and reducing inflammatory cytokines.